TTY Biopharm

Industry · 13 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Recruiting	A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfon Bacteremia Caused by Gram-Negative Bacteria, Bacterial Pneumonia	—	2025-11-26
Completed	A Pharmacokinetic Study of Polymyxin B in Healthy Subjects and Subjects With Renal Insufficiency Antibiotic Toxicity	Phase 1	2022-07-26
Terminated	A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in Taiwan Resected Pancreatic Cancer, Pancreatic Cancer, Adjuvant Chemotherapy	Phase 2	2019-07-11
Completed	A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent Fever Neutropenia, Febrile	—	2016-05-24
Unknown	Megestrol Acetate Against Cancer-related Critical Body Weight Loss in Patients With H&N Cancer Who Receiving C Head and Neck Cancer	Phase 2	2015-05-01
Completed	A Study of S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Advanced Biliary Tract Cancer(BTC)	Phase 2	2015-04-01
Completed	TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated mCRC Metastatic Colorectal Cancer	Phase 2	2014-07-05
Completed	Efficacy and Safety of Alginos Oral Suspension to Treat Laryngopharyngeal Reflux Laryngopharyngeal Reflux	Phase 3	2011-10-01
Completed	A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer Non-small-cell Lung Cancer (NSCLC)	N/A	2011-03-01
Unknown	Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis Cryptococcal Meningitis	N/A	2011-02-01
Unknown	A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Breast Cancer	Phase 2	2010-06-01
Unknown	Lipo-dox and Cyclophosphamide /5-Fluorouracil in Patients With Metastatic Breast Cancer Metastatic Breast Cancer	Phase 2	2005-09-01
Terminated	Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve Carcinoma, Hepatocellular	Phase 3	2003-02-01